This podcast highlights several exciting topics in the drug discovery world, including a new bi-specific treatment for lymphoma, advancements in in-space pharmaceutical manufacturing and a promising depression treatment. It also covers positive interim results of a study on reducing depressive symptoms, the approval of HIV treatment in China, and the approval of a gene therapy trial for young children with Hunter syndrome. Additionally, it discusses the efficient brain delivery of an enzyme for mice with Hunter syndrome using an Apo-E2 tagged sequence.